Beverly Torok-Storb

Beverly Jo Torok-Storb (1948 – May 5, 2023) was an American physician who was Professor of Clinical Research at the

Torok-Storb also worked with an animal model that could predict the outcomes of hematopoietic stem cell transplants in humans.[9]

Torok-Storb was part of the Cooperative Center of Excellence in Hematology.^[10]

Academic service

Torok-Storb was an advocate for building a more inclusive academic culture.^[11] She developed research opportunities for undergraduate students, high school students^[12] and people from historically excluded groups.^[13][14] She said that her mentorship has come from her upbringing, “the only reason I made it as far as I did is because of special teachers along the way who let me know that I was capable and I could do it,”.^[2]

Death

Torok-Storb died at her home in

• P A McSweeney; D Niederwieser; J A Shizuru; et al. (1 June 2001). "Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects".
  Wikidata Q40706569
  .
• Simmons PJ; Torok-Storb B (1 July 1991). "Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1".
  Wikidata Q41675626
  .
• Christian W Scharenberg; Michael A Harkey; Beverly Torok-Storb (15 January 2002). "The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors".
  Wikidata Q28214940
  .